ResearcherTel Aviv UniversityActive in the last 2 years

Lior Orbach

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9804-3743; OpenAlex author ID A5066923196. Sources: OpenAlex.

Their work

Papers: 3 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 9

Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 2 papers

Papers 3

Intraoperative Management Strategies for Unresectable Pancreatic Adenocarcinoma: A Propensity-Weighted Cohort Study. Co-author DOI 10.1177/00031348261499335 ↗
Lymph node-targeted Nanovaccine Reshapes the Tumor Microenvironment to Suppress PDAC Progression and Metastasis Co-author DOI 10.21203/rs.3.rs-9958073/v1 ↗
Palliative bypass surgery for patients with advanced pancreatic adenocarcinoma: experience from a tertiary center. First author DOI 10.1186/s12957-020-01828-5 ↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Guy Lahat · 2 shared papers, 2026 · strength 0.60
- Paper Intraoperative Management Strategies for Unresectable Pancreatic Adenocarcinoma: A Propensity-Weighted Cohort Study. DOI 10.1177/00031348261499335 ↗
- Paper Lymph node-targeted Nanovaccine Reshapes the Tumor Microenvironment to Suppress PDAC Progression and Metastasis DOI 10.21203/rs.3.rs-9958073/v1 ↗
Nir Lubezky · 1 shared paper, 2026 · strength 0.36
- Paper Intraoperative Management Strategies for Unresectable Pancreatic Adenocarcinoma: A Propensity-Weighted Cohort Study. DOI 10.1177/00031348261499335 ↗
Daniella Vaskovich‐Koubi · 1 shared paper, 2026 · strength 0.24
- Paper Lymph node-targeted Nanovaccine Reshapes the Tumor Microenvironment to Suppress PDAC Progression and Metastasis DOI 10.21203/rs.3.rs-9958073/v1 ↗
Helena F. Florindo · 1 shared paper, 2026 · strength 0.24
- Paper Lymph node-targeted Nanovaccine Reshapes the Tumor Microenvironment to Suppress PDAC Progression and Metastasis DOI 10.21203/rs.3.rs-9958073/v1 ↗
Ronit Satchi‐Fainaro · 1 shared paper, 2026 · strength 0.24
- Paper Lymph node-targeted Nanovaccine Reshapes the Tumor Microenvironment to Suppress PDAC Progression and Metastasis DOI 10.21203/rs.3.rs-9958073/v1 ↗
Dov Hershkovitz · 1 shared paper, 2026 · strength 0.24
- Paper Lymph node-targeted Nanovaccine Reshapes the Tumor Microenvironment to Suppress PDAC Progression and Metastasis DOI 10.21203/rs.3.rs-9958073/v1 ↗
Boaz Sagie · 1 shared paper, 2020 · strength 0.11
- Paper Palliative bypass surgery for patients with advanced pancreatic adenocarcinoma: experience from a tertiary center. DOI 10.1186/s12957-020-01828-5 ↗
Niv Pencovich · 1 shared paper, 2020 · strength 0.11
- Paper Palliative bypass surgery for patients with advanced pancreatic adenocarcinoma: experience from a tertiary center. DOI 10.1186/s12957-020-01828-5 ↗
Ido Nachmany · 1 shared paper, 2020 · strength 0.11
- Paper Palliative bypass surgery for patients with advanced pancreatic adenocarcinoma: experience from a tertiary center. DOI 10.1186/s12957-020-01828-5 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.